PMID- 15576845 OWN - NLM STAT- MEDLINE DCOM- 20050711 LR - 20210217 IS - 0022-2275 (Print) IS - 0022-2275 (Linking) VI - 46 IP - 2 DP - 2005 Feb TI - Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis. PG - 287-96 AB - Cerebrotendinous xanthomatosis (CTX), sterol 27-hydroxylase (CYP27A1) deficiency, is associated with markedly reduced chenodeoxycholic acid (CDCA), the most powerful activating ligand for farnesoid X receptor (FXR). We investigated the effects of reduced CDCA on FXR target genes in humans. Liver specimens from an untreated CTX patient and 10 control subjects were studied. In the patient, hepatic CDCA concentration was markedly reduced but the bile alcohol level exceeded CDCA levels in control subjects (73.5 vs. 37.8 +/- 6.2 nmol/g liver). Cholesterol 7alpha-hydroxylase (CYP7A1) and Na+/taurocholate-cotransporting polypeptide (NTCP) were upregulated 84- and 8-fold, respectively. However, small heterodimer partner (SHP) and bile salt export pump were normally expressed. Marked CYP7A1 induction with normal SHP expression was not explained by the regulation of liver X receptor alpha (LXRalpha) or pregnane X receptor. However, another nuclear receptor, hepatocyte nuclear factor 4alpha (HNF4alpha), was induced 2.9-fold in CTX, which was associated with enhanced mRNA levels of HNF4alpha target genes, CYP7A1, 7alpha-hydroxy-4-cholesten-3-one 12alpha-hydroxylase, CYP27A1, and NTCP. In conclusion, the coordinate regulation of FXR target genes was lost in CTX. The mechanism of the disruption may be explained by a normally stimulated FXR pathway attributable to markedly increased bile alcohols with activation of HNF4alpha caused by reduced bile acids in CTX liver. FAU - Honda, Akira AU - Honda A AD - Ibaraki Prefectural Institute of Public Health, Mito, Ibaraki 310-0852, Japan. akihonda-gi@umin.ac.jp FAU - Salen, Gerald AU - Salen G FAU - Matsuzaki, Yasushi AU - Matsuzaki Y FAU - Batta, Ashok K AU - Batta AK FAU - Xu, Guorong AU - Xu G FAU - Hirayama, Takeshi AU - Hirayama T FAU - Tint, G Stephen AU - Tint GS FAU - Doy, Mikio AU - Doy M FAU - Shefer, Sarah AU - Shefer S LA - eng GR - DK-26756/DK/NIDDK NIH HHS/United States GR - DK-56830/DK/NIDDK NIH HHS/United States PT - Case Reports PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. DEP - 20041201 PL - United States TA - J Lipid Res JT - Journal of lipid research JID - 0376606 RN - 0 (ABCB11 protein, human) RN - 0 (ATP Binding Cassette Transporter, Subfamily B, Member 11) RN - 0 (ATP-Binding Cassette Transporters) RN - 0 (Alcohols) RN - 0 (Bile Acids and Salts) RN - 0 (Cholestanols) RN - 0 (DNA Primers) RN - 0 (DNA-Binding Proteins) RN - 0 (HNF4A protein, human) RN - 0 (Hepatocyte Nuclear Factor 4) RN - 0 (Liver X Receptors) RN - 0 (Membrane Transport Proteins) RN - 0 (NR1H3 protein, human) RN - 0 (Organic Anion Transporters, Sodium-Dependent) RN - 0 (Orphan Nuclear Receptors) RN - 0 (Phosphoproteins) RN - 0 (Pregnane X Receptor) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Cytoplasmic and Nuclear) RN - 0 (Receptors, Steroid) RN - 0 (Symporters) RN - 0 (Transcription Factors) RN - 0 (nuclear receptor subfamily 0, group B, member 2) RN - 0C5V0MRU6P (farnesoid X-activated receptor) RN - 0GEI24LG0J (Chenodeoxycholic Acid) RN - 145420-23-1 (sodium-bile acid cotransporter) RN - EC 1.14.- (Steroid Hydroxylases) RN - EC 1.14.14.23 (Cholesterol 7-alpha-Hydroxylase) RN - EC 1.14.15.15 (CYP27A1 protein, human) RN - EC 1.14.15.15 (Cholestanetriol 26-Monooxygenase) SB - IM MH - ATP Binding Cassette Transporter, Subfamily B, Member 11 MH - ATP-Binding Cassette Transporters/biosynthesis MH - Adult MH - Alcohols/metabolism MH - Bile Acids and Salts/metabolism MH - Case-Control Studies MH - Chenodeoxycholic Acid/metabolism MH - Cholestanetriol 26-Monooxygenase MH - Cholestanols/metabolism MH - Cholesterol 7-alpha-Hydroxylase/biosynthesis MH - DNA Primers/metabolism MH - DNA-Binding Proteins/biosynthesis/*genetics/*metabolism MH - Female MH - Gene Expression Regulation MH - Hepatocyte Nuclear Factor 4 MH - Humans MH - Liver/metabolism MH - Liver X Receptors MH - Male MH - Membrane Transport Proteins/biosynthesis MH - Middle Aged MH - Models, Biological MH - Organic Anion Transporters, Sodium-Dependent MH - Orphan Nuclear Receptors MH - Phosphoproteins/biosynthesis MH - Pregnane X Receptor MH - Protein Binding MH - RNA, Messenger/metabolism MH - Receptors, Cytoplasmic and Nuclear/biosynthesis MH - Receptors, Steroid/biosynthesis MH - Steroid Hydroxylases/biosynthesis MH - Symporters MH - Transcription Factors/biosynthesis/*genetics/*metabolism MH - Up-Regulation MH - Xanthomatosis, Cerebrotendinous/*genetics/*metabolism EDAT- 2004/12/04 09:00 MHDA- 2005/07/12 09:00 CRDT- 2004/12/04 09:00 PHST- 2004/12/04 09:00 [pubmed] PHST- 2005/07/12 09:00 [medline] PHST- 2004/12/04 09:00 [entrez] AID - S0022-2275(20)34062-1 [pii] AID - 10.1194/jlr.M400256-JLR200 [doi] PST - ppublish SO - J Lipid Res. 2005 Feb;46(2):287-96. doi: 10.1194/jlr.M400256-JLR200. Epub 2004 Dec 1.